Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 2-phenyl-3,4-dihydropyrrolo[2,1 -f] [1,2,4]triazinone derivatives as phosphodiesterase inhibitors and uses thereof

2-phenyl-3,4-dihydropyrrolo[2,1 -f] [1,2,4]triazinone derivatives as phosphodiesterase inhibitors and uses thereof

US Patent 11897890 · Granted Feb 13, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Dual mode of action soluble guanylate cyclase activators and phosphodiesterase i2025
Dual mode of action soluble guanylate cyclase activators and phosphodiesterase i2025
2-phenyl-3,4-dihydropyrrolo[2,1-f] [1,2,4]triazinone derivatives as phosphodiest2025
2-phenyl-3,4-dihydropyrrolo[2,1-f] [1,2,4]triazinone derivatives as phosphodiest2025
Dual mode of action soluble guanylate cyclase activators and phosphodiesterase i2024
Dual mode of action soluble guanylate cyclase activators and phosphodiesterase i2024
2-phenyl-3,4-dihydropyrrolo[2,1-Ff] [1,2,4]triazinone derivatives as phosphodies2022
2-phenyl-3,4-dihydropyrrolo[2,1-Ff] [1,2,4]triazinone derivatives as phosphodies2022
Dual mode of action soluble guanylate cyclase activators and phosphodiesterase i2021
Dual mode of action soluble guanylate cyclase activators and phosphodiesterase i2021
2-phenyl-3,4-dihydropyrrolo[2,1 -F] [1,2,4]triazinone derivatives as phosphodies2020
2-phenyl-3,4-dihydropyrrolo[2,1 -F] [1,2,4]triazinone derivatives as phosphodies2020